Insider Selling: Aflac (NYSE:AFL) Major Shareholder Sells $1,982,493.00 in Stock

Aflac Incorporated (NYSE:AFL) major shareholder Post Holdings Co. Ltd. Japan sold 18,100 shares of the stock in a transaction that occurred on Wednesday, March 11th. The stock was sold at an average price of $109.53, for a total transaction of $1,982,493.00. Following the sale, the insider directly owned 52,168,000 shares of the company’s stock, valued at approximately $5,713,961,040. This trade represents a 0.03% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Major shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.

Post Holdings Co. Ltd. Japan also recently made the following trade(s):

• On Tuesday, March 10th, Post Holdings Co. Ltd. Japan sold 19,000 shares of Aflac stock. The shares were sold at an average price of $110.47, for a total transaction of $2,098,930.00.
• On Monday, March 9th, Post Holdings Co. Ltd. Japan sold 17,300 shares of Aflac stock. The stock was sold at an average price of $109.62, for a total transaction of $1,896,426.00.
• On Friday, March 6th, Post Holdings Co. Ltd. Japan sold 19,100 shares of Aflac stock. The stock was sold at an average price of $110.77, for a total transaction of $2,115,707.00.
• On Thursday, March 5th, Post Holdings Co. Ltd. Japan sold 19,300 shares of Aflac stock. The shares were sold at an average price of $110.96, for a total transaction of $2,141,528.00.

Aflac Stock Performance

NYSE:AFL opened at $108.73 on Monday. The firm’s fifty day simple moving average is $111.63 and its 200 day simple moving average is $110.33. The company has a current ratio of 0.11, a quick ratio of 0.11 and a debt-to-equity ratio of 0.29. Aflac Incorporated has a twelve month low of $96.95 and a twelve month high of $119.32. The firm has a market capitalization of $56.14 billion, a price-to-earnings ratio of 15.80, a PEG ratio of 3.56 and a beta of 0.66.

Aflac (NYSE:AFL) last announced its quarterly earnings results on Wednesday, February 4th. The financial services provider reported $1.57 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.69 by ($0.12). Aflac had a net margin of 21.24% and a return on equity of 14.35%. The company had revenue of $4.28 billion during the quarter, compared to analyst estimates of $4.45 billion. During the same quarter in the prior year, the company posted $1.57 earnings per share. The firm’s revenue for the quarter was down 9.6% on a year-over-year basis. As a group, equities research analysts expect that Aflac Incorporated will post 6.88 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Aflac

Several institutional investors and hedge funds have recently bought and sold shares of the business. True Wealth Design LLC boosted its stake in Aflac by 188.5% in the third quarter. True Wealth Design LLC now owns 225 shares of the financial services provider’s stock valued at $25,000 after acquiring an additional 147 shares during the period. Quarry LP acquired a new stake in shares of Aflac during the 4th quarter worth approximately $25,000. Nalls Sherbakoff Group LLC acquired a new stake in shares of Aflac during the 4th quarter worth approximately $29,000. Navalign LLC bought a new stake in shares of Aflac in the 4th quarter worth approximately $32,000. Finally, Darwin Wealth Management LLC bought a new stake in shares of Aflac in the 2nd quarter worth approximately $33,000. Institutional investors and hedge funds own 67.44% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on AFL shares. TD Cowen reiterated a “hold” rating on shares of Aflac in a report on Monday, December 22nd. Raymond James Financial restated an “outperform” rating and issued a $119.00 price target (up from $110.00) on shares of Aflac in a report on Tuesday, December 30th. Mizuho set a $107.00 price objective on shares of Aflac in a research report on Monday, February 9th. Morgan Stanley set a $120.00 price objective on shares of Aflac in a research note on Monday, December 15th. Finally, Wall Street Zen cut shares of Aflac from a “hold” rating to a “sell” rating in a research report on Saturday, February 28th. Three equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the company’s stock. Based on data from MarketBeat, Aflac currently has an average rating of “Hold” and an average price target of $111.73.

More Aflac News

Here are the key news stories impacting Aflac this week:

• Positive Sentiment: New distribution deal: Aflac announced a partnership with Empower Brokerage to distribute supplemental-insurance products, which should broaden channels for sales and support premium growth over time. Read More.
• Neutral Sentiment: Earnings/fundamentals context: Aflac’s Feb. 4 quarter showed an EPS miss and revenue decline year-over-year; consensus remains a “Hold” with an average target around $111. That keeps analysts cautious and caps upside absent clearer improvement in top-line trends.
• Neutral Sentiment: Human-interest coverage: Aflac ran a feature on a policyholder’s cancer journey (brand/PR positive but unlikely to move the stock materially). Read More.
• Negative Sentiment: Director insider sale: Director Charles D. Lake II sold 15,590 shares (avg. ~$109.93) on Mar. 11. Insider sales can be read negatively by the market even if motivated by personal reasons; SEC Form 4 filed. Read More.
• Negative Sentiment: Major shareholder trimming: Post Holdings (Japan) has executed several small block sales (multiple ~17k–19k-share trades across Mar. 5–11). Sales are small relative to its >10% stake but add supply and suggest portfolio rebalancing rather than confidence-boosting buying. Read More.
• Negative Sentiment: Cybersecurity incident disclosed: Media reports say Aflac confirmed a cybersecurity breach; details remain limited. Potential data, remediation costs, regulatory follow-ups or client impact make this the most direct near‑term operational risk in the headlines. Read More.

Aflac Company Profile

Aflac Incorporated (American Family Life Assurance Company of Columbus) is a provider of supplemental insurance products designed to help policyholders manage out-of-pocket health care and living expenses. The company underwrites a range of individual and group policies that typically pay cash benefits directly to insureds when covered events occur, enabling greater financial flexibility for medical treatment, hospital stays, critical illness, and related costs. Aflac’s product mix includes supplemental health insurance, life insurance and other specialty coverages intended to complement primary medical plans.

Founded in the mid-20th century and headquartered in Columbus, Georgia, Aflac distributes its products through a combination of employer-sponsored programs, independent brokers and agents, and direct marketing.